222 related articles for article (PubMed ID: 17351965)
1. Introduction to chemical proteomics for drug discovery and development.
Han SY; Hwan Kim S
Arch Pharm (Weinheim); 2007 Apr; 340(4):169-77. PubMed ID: 17351965
[TBL] [Abstract][Full Text] [Related]
2. Surface-plasmon-resonance-based chemical proteomics: efficient specific extraction and semiquantitative identification of cyclic nucleotide-binding proteins from cellular lysates by using a combination of surface plasmon resonance, sequential elution and liquid chromatography-tandem mass spectrometry.
Visser NF; Scholten A; van den Heuvel RH; Heck AJ
Chembiochem; 2007 Feb; 8(3):298-305. PubMed ID: 17206730
[TBL] [Abstract][Full Text] [Related]
3. Surface plasmon resonance mass spectrometry in proteomics.
Visser NF; Heck AJ
Expert Rev Proteomics; 2008 Jun; 5(3):425-33. PubMed ID: 18532910
[TBL] [Abstract][Full Text] [Related]
4. [The application of small molecule bioactive probes in the identification of cellular targets].
Zhang J; Zhou HC
Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
[TBL] [Abstract][Full Text] [Related]
5. Chemical proteomics and its impact on the drug discovery process.
Miao Q; Zhang CC; Kast J
Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
[TBL] [Abstract][Full Text] [Related]
6. Chemical proteomics-based drug design: target and antitarget fishing with a catechol-rhodanine privileged scaffold for NAD(P)(H) binding proteins.
Ge X; Wakim B; Sem DS
J Med Chem; 2008 Aug; 51(15):4571-80. PubMed ID: 18616236
[TBL] [Abstract][Full Text] [Related]
7. Pathway proteomics and chemical proteomics team up in drug discovery.
Hopf C; Bantscheff M; Drewes G
Neurodegener Dis; 2007; 4(2-3):270-80. PubMed ID: 17596721
[TBL] [Abstract][Full Text] [Related]
8. [Comparative chemical proteomics: simultaneous identification of disease-specific protein targets and their small molecule-binding partners, suitable as drug candidates].
Dormán G; Puskás LG; Fehér LZ; Hackler L; Lorincz Z; Lang C; Urge L; Darvas F
Acta Pharm Hung; 2006; 76(1):3-9. PubMed ID: 17094670
[TBL] [Abstract][Full Text] [Related]
9. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
Katayama H; Oda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
[TBL] [Abstract][Full Text] [Related]
10. An immuno-chemo-proteomics method for drug target deconvolution.
Saxena C; Zhen E; Higgs RE; Hale JE
J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
[TBL] [Abstract][Full Text] [Related]
11. Activity-based proteomics: enzymatic activity profiling in complex proteomes.
Schmidinger H; Hermetter A; Birner-Gruenberger R
Amino Acids; 2006 Jun; 30(4):333-50. PubMed ID: 16773240
[TBL] [Abstract][Full Text] [Related]
12. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
Hu S; Yen Y; Ann D; Wong DT
Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
[TBL] [Abstract][Full Text] [Related]
13. Structural proteomics in drug discovery.
Tari LW; Rosenberg M; Schryvers AB
Expert Rev Proteomics; 2005 Aug; 2(4):511-9. PubMed ID: 16097885
[TBL] [Abstract][Full Text] [Related]
14. Drug target deconvolution by chemical proteomics.
Raida M
Curr Opin Chem Biol; 2011 Aug; 15(4):570-5. PubMed ID: 21763176
[TBL] [Abstract][Full Text] [Related]
15. Proteomics, nanotechnology and molecular diagnostics.
Johnson CJ; Zhukovsky N; Cass AE; Nagy JM
Proteomics; 2008 Feb; 8(4):715-30. PubMed ID: 18297650
[TBL] [Abstract][Full Text] [Related]
16. Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.
Ong SE; Li X; Schenone M; Schreiber SL; Carr SA
Methods Mol Biol; 2012; 803():129-40. PubMed ID: 22065222
[TBL] [Abstract][Full Text] [Related]
17. Proteomics technologies for identification and validation of protein targets.
Hale JE; Ou W; Shiyanov P; Knierman MD; Ludwig JR
Methods Biochem Anal; 2005; 45():159-80. PubMed ID: 19235295
[No Abstract] [Full Text] [Related]
18. Chemistry-based functional proteomics for drug target deconvolution.
Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
[TBL] [Abstract][Full Text] [Related]
19. Identification of the cellular targets of bioactive small organic molecules using affinity reagents.
Leslie BJ; Hergenrother PJ
Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161
[TBL] [Abstract][Full Text] [Related]
20. Chemical microarrays, fragment diversity, label-free imaging by plasmon resonance--a chemical genomics approach.
Vetter D
J Cell Biochem Suppl; 2002; 39():79-84. PubMed ID: 12552606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
